表紙：スマートインスリンペンの世界市場 - 機会分析・業界予測（2020年～2030年）：タイプ別、使用形態別、エンドユーザー別

市場調査レポート

商品コード

1097713

スマートインスリンペンの世界市場 - 機会分析・業界予測（2020年～2030年）：タイプ別、使用形態別、エンドユーザー別

Smart Insulin Pens Market By Type, By Usability, By End User : Global Opportunity Analysis and Industry Forecast, 2020-2030

出版日: 2022年04月01日 | 発行: Allied Market Research

| ページ情報: 英文 170 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 5,769 904,348円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,450 1,011,102円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 10,995 1,723,576円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のスマートインスリンペンの市場規模は、2020年に9,480万米ドルと評価され、2021年～2030年にかけて12.2％のCAGRで成長し、2030年には2億9,890万米ドルに達すると予想されています。

インスリンポンプと比較すると、インスリンペンの需要は、糖尿病患者の急増により、インスリンペンの費用対効果の高い性質と相まって近年大幅に増加しています。また、シンプルな機能とインスリン投与に関する正確さが、さらに需要を喚起しています。しかし、2種類のインスリンを1つのインスリンペン内で混合できないといったインスリンペンの使用に関連する欠点により、注射の頻度を増やす必要性があり、これが市場の成長を阻害するでしょう。

当レポートでは、世界のスマートインスリンペン市場を調査分析し、市場概要、セグメント別・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

概要
- 市場規模と予測
第一世代のペン
- 主要な市場動向、成長要因および機会
- 市場規模と予測：地域別
- 市場分析：国別
第二世代のペン
- 主要な市場動向、成長要因および機会
- 市場規模と予測：地域別
- 市場分析：国別

第5章スマートインスリンペン市場：使用形態別

概要
- 市場規模と予測
プレフィルド型
- 主要な市場動向、成長要因および機会
- 市場規模と予測：地域別
- 市場分析：国別
リユース型
- 主要な市場動向、成長要因および機会
- 市場規模と予測：地域別
- 市場分析：国別

第6章スマートインスリンペン市場：エンドユーザー別

概要
- 市場規模と予測
病院・クリニック
- 主要な市場動向、成長要因および機会
- 市場規模と予測：地域別
- 市場分析：国別
外来手術センター
- 主要な市場動向、成長要因および機会
- 市場規模と予測：地域別
- 市場分析：国別
在宅医療
- 主要な市場動向、成長要因および機会
- 市場規模と予測：地域別
- 市場分析：国別

第7章スマートインスリンペン市場：地域別

概要
- 市場規模と予測
北米
- 主な動向と機会
- 北米市場の規模と予測：タイプ別
- 北米市場の規模と予測：使用形態別
- 北米市場の規模と予測：エンドユーザー別
- 北米市場の規模と予測：国別
  - 米国
  - カナダ
  - メキシコ
欧州
- 主な動向と機会
- 欧州市場の規模と予測：タイプ別
- 欧州市場の規模と予測：使用形態別
- 欧州市場の規模と予測：エンドユーザー別
- 欧州市場の規模と予測：国別
  - ドイツ
  - フランス
  - 英国
  - イタリア
  - スペイン
  - その他欧州
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域市場の規模と予測：タイプ別
- アジア太平洋地域市場の規模と予測：使用形態別
- アジア太平洋地域市場の規模と予測：エンドユーザー別
- アジア太平洋地域市場の規模と予測：国別
  - 日本
  - 中国
  - インド
  - オーストラリア
  - その他アジア太平洋地域
ラテンアメリカ・中東・アフリカ
- 主な動向と機会
- ラテンアメリカ・中東・アフリカ市場の規模と予測：タイプ別
- ラテンアメリカ・中東・アフリカ市場の規模と予測：使用形態別
- ラテンアメリカ・中東・アフリカ市場の規模と予測：エンドユーザー別
- ラテンアメリカ・中東・アフリカ市場の規模と予測：国別
  - ブラジル
  - サウジアラビア
  - 南アフリカ
  - その他ラテンアメリカ・中東・アフリカ

第8章企業情勢

イントロダクション
主な成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合ヒートマップ
主な発展

第9章企業プロファイル

Emperra GmbH
Jiangsu Deflu Medical Device Co. Ltd.
Medtronic plc
Novo Nordisk
Pendiq
Sanofi
Berlin-Chemie
Bigfoot Biomedical
Digital Medics Pty Ltd.
Eli Lilly and Company

図表

LIST OF TABLES

TABLE 1. GLOBAL SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 2. SMART INSULIN PENS MARKET SIZE, FOR FIRST GENERATION PENS, BY REGION, 2020-2030 ($MILLION)
TABLE 3. SMART INSULIN PENS MARKET FOR FIRST GENERATION PENS, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 4. SMART INSULIN PENS MARKET SIZE, FOR SECOND GENERATION PENS, BY REGION, 2020-2030 ($MILLION)
TABLE 5. SMART INSULIN PENS MARKET FOR SECOND GENERATION PENS, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 6. GLOBAL SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 7. SMART INSULIN PENS MARKET SIZE, FOR PREFILLED, BY REGION, 2020-2030 ($MILLION)
TABLE 8. SMART INSULIN PENS MARKET FOR PREFILLED, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 9. SMART INSULIN PENS MARKET SIZE, FOR REUSABLE, BY REGION, 2020-2030 ($MILLION)
TABLE 10. SMART INSULIN PENS MARKET FOR REUSABLE, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 11. GLOBAL SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 12. SMART INSULIN PENS MARKET SIZE, FOR HOSPITALS AND CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 13. SMART INSULIN PENS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 14. SMART INSULIN PENS MARKET SIZE, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020-2030 ($MILLION)
TABLE 15. SMART INSULIN PENS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 16. SMART INSULIN PENS MARKET SIZE, FOR HOME CARE SETTINGS, BY REGION, 2020-2030 ($MILLION)
TABLE 17. SMART INSULIN PENS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 18. SMART INSULIN PENS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 19. NORTH AMERICA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 20. NORTH AMERICA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 21. NORTH AMERICA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 22. NORTH AMERICA SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 23. U.S. SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 24. U.S. SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 25. U.S. SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 26. CANADA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 27. CANADA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 28. CANADA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 29. MEXICO SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 30. MEXICO SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 31. MEXICO SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 32. EUROPE SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 33. EUROPE SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 34. EUROPE SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35. EUROPE SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 36. GERMANY SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 37. GERMANY SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 38. GERMANY SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 39. FRANCE SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 40. FRANCE SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 41. FRANCE SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 42. U.K. SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 43. U.K. SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 44. U.K. SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 45. ITALY SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 46. ITALY SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 47. ITALY SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48. SPAIN SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 49. SPAIN SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 50. SPAIN SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 51. REST OF EUROPE SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 52. REST OF EUROPE SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 53. REST OF EUROPE SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 54. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 55. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 56. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 58. JAPAN SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 59. JAPAN SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 60. JAPAN SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 61. CHINA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 62. CHINA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 63. CHINA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 64. INDIA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 65. INDIA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 66. INDIA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 67. AUSTRALIA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 68. AUSTRALIA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 69. AUSTRALIA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 73. LAMEA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 74. LAMEA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 75. LAMEA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 76. LAMEA SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 77. BRAZIL SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 78. BRAZIL SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 79. BRAZIL SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 80. SAUDI ARABIA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 81. SAUDI ARABIA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 82. SAUDI ARABIA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 83. SOUTH AFRICA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 84. SOUTH AFRICA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 85. SOUTH AFRICA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 86. REST OF LAMEA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 87. REST OF LAMEA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
TABLE 88. REST OF LAMEA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 89.EMPERRA GMBH: COMPANY SNAPSHOT
TABLE 90.EMPERRA GMBH: OPERATING SEGMENTS
TABLE 91.EMPERRA GMBH: PRODUCT PORTFOLIO
TABLE 92.EMPERRA GMBH: NET SALES,
TABLE 93.EMPERRA GMBH: KEY STRATERGIES
TABLE 94.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: COMPANY SNAPSHOT
TABLE 95.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: OPERATING SEGMENTS
TABLE 96.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: PRODUCT PORTFOLIO
TABLE 97.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: NET SALES,
TABLE 98.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: KEY STRATERGIES
TABLE 99.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 100.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 101.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 102.MEDTRONIC PLC: NET SALES,
TABLE 103.MEDTRONIC PLC: KEY STRATERGIES
TABLE 104.NOVO NORDISK: COMPANY SNAPSHOT
TABLE 105.NOVO NORDISK: OPERATING SEGMENTS
TABLE 106.NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 107.NOVO NORDISK: NET SALES,
TABLE 108.NOVO NORDISK: KEY STRATERGIES
TABLE 109.PENDIQ: COMPANY SNAPSHOT
TABLE 110.PENDIQ: OPERATING SEGMENTS
TABLE 111.PENDIQ: PRODUCT PORTFOLIO
TABLE 112.PENDIQ: NET SALES,
TABLE 113.PENDIQ: KEY STRATERGIES
TABLE 114.SANOFI: COMPANY SNAPSHOT
TABLE 115.SANOFI: OPERATING SEGMENTS
TABLE 116.SANOFI: PRODUCT PORTFOLIO
TABLE 117.SANOFI: NET SALES,
TABLE 118.SANOFI: KEY STRATERGIES
TABLE 119.BERLIN-CHEMIE: COMPANY SNAPSHOT
TABLE 120.BERLIN-CHEMIE: OPERATING SEGMENTS
TABLE 121.BERLIN-CHEMIE: PRODUCT PORTFOLIO
TABLE 122.BERLIN-CHEMIE: NET SALES,
TABLE 123.BERLIN-CHEMIE: KEY STRATERGIES
TABLE 124.BIGFOOT BIOMEDICAL: COMPANY SNAPSHOT
TABLE 125.BIGFOOT BIOMEDICAL: OPERATING SEGMENTS
TABLE 126.BIGFOOT BIOMEDICAL: PRODUCT PORTFOLIO
TABLE 127.BIGFOOT BIOMEDICAL: NET SALES,
TABLE 128.BIGFOOT BIOMEDICAL: KEY STRATERGIES
TABLE 129.DIGITAL MEDICS PTY LTD.: COMPANY SNAPSHOT
TABLE 130.DIGITAL MEDICS PTY LTD.: OPERATING SEGMENTS
TABLE 131.DIGITAL MEDICS PTY LTD.: PRODUCT PORTFOLIO
TABLE 132.DIGITAL MEDICS PTY LTD.: NET SALES,
TABLE 133.DIGITAL MEDICS PTY LTD.: KEY STRATERGIES
TABLE 134.ELI LILLY AND COMPANY: COMPANY SNAPSHOT
TABLE 135.ELI LILLY AND COMPANY: OPERATING SEGMENTS
TABLE 136.ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
TABLE 137.ELI LILLY AND COMPANY: NET SALES,
TABLE 138.ELI LILLY AND COMPANY: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.SMART INSULIN PENS MARKET SEGMENTATION
FIGURE 2.SMART INSULIN PENS MARKET,2020-2030
FIGURE 3.SMART INSULIN PENS MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.SMART INSULIN PENS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.SMART INSULIN PENS MARKET,BY TYPE,2020(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF FIRST GENERATION PENS SMART INSULIN PENS MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SECOND GENERATION PENS SMART INSULIN PENS MARKET,2020-2030(%)
FIGURE 15.SMART INSULIN PENS MARKET,BY USABILITY,2020(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PREFILLED SMART INSULIN PENS MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF REUSABLE SMART INSULIN PENS MARKET,2020-2030(%)
FIGURE 18.SMART INSULIN PENS MARKET,BY END USER,2020(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS SMART INSULIN PENS MARKET,2020-2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS SMART INSULIN PENS MARKET,2020-2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOME CARE SETTINGS SMART INSULIN PENS MARKET,2020-2030(%)
FIGURE 22.SMART INSULIN PENS MARKET BY REGION,2020
FIGURE 23.U.S. SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 24.CANADA SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 25.MEXICO SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 26.GERMANY SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 27.FRANCE SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 28.U.K. SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 29.ITALY SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 30.SPAIN SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 31.REST OF EUROPE SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 32.JAPAN SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 33.CHINA SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 34.INDIA SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 35.AUSTRALIA SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 36.REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 37.BRAZIL SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 38.SAUDI ARABIA SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 39.SOUTH AFRICA SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 40.REST OF LAMEA SMART INSULIN PENS MARKET,2020-2030($MILLION)
FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 45.COMPETITIVE DASHBOARD
FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 47.EMPERRA GMBH.: NET SALES ,($MILLION)
FIGURE 48.JIANGSU DEFLU MEDICAL DEVICE CO. LTD..: NET SALES ,($MILLION)
FIGURE 49.MEDTRONIC PLC.: NET SALES ,($MILLION)
FIGURE 50.NOVO NORDISK.: NET SALES ,($MILLION)
FIGURE 51.PENDIQ.: NET SALES ,($MILLION)
FIGURE 52.SANOFI.: NET SALES ,($MILLION)
FIGURE 53.BERLIN-CHEMIE.: NET SALES ,($MILLION)
FIGURE 54.BIGFOOT BIOMEDICAL.: NET SALES ,($MILLION)
FIGURE 55.DIGITAL MEDICS PTY LTD..: NET SALES ,($MILLION)
FIGURE 56.ELI LILLY AND COMPANY.: NET SALES ,($MILLION)

Product Code: A03145

The global smart insulin pens market was valued at $94.8 million in 2020, and is estimated to reach $298.9 million by 2030, growing at a CAGR of 12.2% from 2021 to 2030.

Smart insulin pens are used for external insulin delivery thus offering an easy to carry solution for diabetes management. Different kinds of smart insulin pens and associated devices, such as smart pen caps, are in the market, and smart insulin pens with connectivity are defined as those with built-in interface technology.

The demand for insulin pens has increased considerably in the recent years owing to surge in incidence of diabetic patients coupled with the cost-effective nature of insulin pens as compared to insulin pumps. In addition, their simple functioning and accuracy related to insulin dosing further stimulates their demand. However, there are certain disadvantages associated with the use of insulin pen such as two types of insulin cannot be mixed in an insulin pen, thus increasing the frequency of injections needed. This in turn impedes the market growth.

The smart insulin pens market is segmented on the basis of type, usability, end user, and region. By type, the market is classified into first generation and second-generation insulin pens. The second-generation insulin pens are further bifurcated into Bluetooth-enabled and USB-connected insulin pens. By usability, it is divided into pre-filled and reusable insulin pumps. According to the end user, the market is classified into hospitals & clinics, ambulatory surgical centers, and home care settings. By region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

The key players that operate in the smart insulin pens market include Berlin-Chemie, Bigfoot Biomedical, Digital Medics Pty Ltd., Eli Lilly and Company, Emperra GmbH, Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Novo Nordisk, Pendiq and Sanofi.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the smart insulin pens market analysis from 2020 to 2030 to identify the prevailing smart insulin pens market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the smart insulin pens market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global smart insulin pens market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By End User

Hospitals and Clinics
Ambulatory Surgical Centers
Home Care Settings

By Type

First Generation Pens
Second Generation Pens

By Usability

Prefilled
Reusable

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Emperra GmbH
- Jiangsu Deflu Medical Device Co. Ltd.
- Medtronic plc
- Novo Nordisk
- Pendiq
- Sanofi
- Berlin-Chemie
- Bigfoot Biomedical
- Digital Medics Pty Ltd.
- Eli Lilly and Company

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SMART INSULIN PENS MARKET, BY TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2 First Generation Pens
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Second Generation Pens
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country

CHAPTER 5: SMART INSULIN PENS MARKET, BY USABILITY

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Prefilled
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Reusable
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country

CHAPTER 6: SMART INSULIN PENS MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Hospitals and Clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Ambulatory Surgical Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Home Care Settings
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: SMART INSULIN PENS MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Usability
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Type
  - 7.2.5.1.2 Market size and forecast, by Usability
  - 7.2.5.1.3 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Type
  - 7.2.5.2.2 Market size and forecast, by Usability
  - 7.2.5.2.3 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Type
  - 7.2.5.3.2 Market size and forecast, by Usability
  - 7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Usability
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Type
  - 7.3.5.1.2 Market size and forecast, by Usability
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Type
  - 7.3.5.2.2 Market size and forecast, by Usability
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 U.K.
  - 7.3.5.3.1 Market size and forecast, by Type
  - 7.3.5.3.2 Market size and forecast, by Usability
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Type
  - 7.3.5.4.2 Market size and forecast, by Usability
  - 7.3.5.4.3 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Type
  - 7.3.5.5.2 Market size and forecast, by Usability
  - 7.3.5.5.3 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Type
  - 7.3.5.6.2 Market size and forecast, by Usability
  - 7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Usability
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Market size and forecast, by Type
  - 7.4.5.1.2 Market size and forecast, by Usability
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 China
  - 7.4.5.2.1 Market size and forecast, by Type
  - 7.4.5.2.2 Market size and forecast, by Usability
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 India
  - 7.4.5.3.1 Market size and forecast, by Type
  - 7.4.5.3.2 Market size and forecast, by Usability
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 Australia
  - 7.4.5.4.1 Market size and forecast, by Type
  - 7.4.5.4.2 Market size and forecast, by Usability
  - 7.4.5.4.3 Market size and forecast, by End User
  - 7.4.5.5 Rest of Asia-Pacific
  - 7.4.5.5.1 Market size and forecast, by Type
  - 7.4.5.5.2 Market size and forecast, by Usability
  - 7.4.5.5.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Usability
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Type
  - 7.5.5.1.2 Market size and forecast, by Usability
  - 7.5.5.1.3 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Type
  - 7.5.5.2.2 Market size and forecast, by Usability
  - 7.5.5.2.3 Market size and forecast, by End User
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Type
  - 7.5.5.3.2 Market size and forecast, by Usability
  - 7.5.5.3.3 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Type
  - 7.5.5.4.2 Market size and forecast, by Usability
  - 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Emperra GmbH
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 Jiangsu Deflu Medical Device Co. Ltd.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 Medtronic plc
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 Novo Nordisk
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 Pendiq
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 Sanofi
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 Berlin-Chemie
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Bigfoot Biomedical
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Digital Medics Pty Ltd.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 Eli Lilly and Company
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments

スマートインスリンペンの世界市場 - 機会分析・業界予測（2020年～2030年）：タイプ別、使用形態別、エンドユーザー別

Smart Insulin Pens Market By Type, By Usability, By End User : Global Opportunity Analysis and Industry Forecast, 2020-2030

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章スマートインスリンペン市場：タイプ別

第5章スマートインスリンペン市場：使用形態別

第6章スマートインスリンペン市場：エンドユーザー別

第7章スマートインスリンペン市場：地域別

第8章企業情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: SMART INSULIN PENS MARKET, BY TYPE

CHAPTER 5: SMART INSULIN PENS MARKET, BY USABILITY

CHAPTER 6: SMART INSULIN PENS MARKET, BY END USER

CHAPTER 7: SMART INSULIN PENS MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

スマートインスリンペンの世界市場 - 機会分析・業界予測（2020年～2030年）：タイプ別、使用形態別、エンドユーザー別

Smart Insulin Pens Market By Type, By Usability, By End User : Global Opportunity Analysis and Industry Forecast, 2020-2030

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 スマートインスリンペン市場：タイプ別

第5章 スマートインスリンペン市場：使用形態別

第6章 スマートインスリンペン市場：エンドユーザー別

第7章 スマートインスリンペン市場：地域別

第8章 企業情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: SMART INSULIN PENS MARKET, BY TYPE

CHAPTER 5: SMART INSULIN PENS MARKET, BY USABILITY

CHAPTER 6: SMART INSULIN PENS MARKET, BY END USER

CHAPTER 7: SMART INSULIN PENS MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章スマートインスリンペン市場：タイプ別

第5章スマートインスリンペン市場：使用形態別

第6章スマートインスリンペン市場：エンドユーザー別

第7章スマートインスリンペン市場：地域別

第8章企業情勢

第9章企業プロファイル